RPAY:NASDAQRepay Holdings Corporation Analysis
Data as of 2026-06-09 - not real-time
$3.45
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Repay Holdings trades around $3.45, well below its DCF‑derived fair value of $4.16, implying roughly a 71% upside potential. The stock benefits from an attractive forward P/E of 3.2 and a solid gross margin of 75%, but it is hampered by a near‑zero operating margin and a steep net loss (-82.7% profit margin). Cash generation looks modest with $44.7 M in cash versus $401 M in debt, yielding a high debt‑to‑equity ratio that adds balance‑sheet risk. Recent corporate actions—most notably the board’s rejection of a 75% premium cash offer from activist Forager Capital and the integration of the KUBRA acquisition—have sparked shareholder tension and could drive short‑term volatility.
Technical signals are mixed: the 20‑day SMA ($3.57) sits just above the current price, the 50‑day SMA ($3.45) aligns with it, and the MACD histogram is negative, indicating a bearish tilt, while the RSI at 45 suggests no clear overbought/oversold condition. Volatility is elevated at **71%** over the past month and beta exceeds **1.6**, pointing to heightened market sensitivity. Volume is trending upward, supporting liquidity, but the combination of high leverage, activist pressure, and bearish technical cues warrants a cautious stance despite the valuation upside.
Technical signals are mixed: the 20‑day SMA ($3.57) sits just above the current price, the 50‑day SMA ($3.45) aligns with it, and the MACD histogram is negative, indicating a bearish tilt, while the RSI at 45 suggests no clear overbought/oversold condition. Volatility is elevated at **71%** over the past month and beta exceeds **1.6**, pointing to heightened market sensitivity. Volume is trending upward, supporting liquidity, but the combination of high leverage, activist pressure, and bearish technical cues warrants a cautious stance despite the valuation upside.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Activist shareholder pressure and board stalemate
- Bearish MACD histogram and proximity to support level
- High volatility and beta indicating price swings
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Significant valuation upside versus DCF fair value
- Forward earnings visibility and low forward P/E
- Potential revenue synergies from the KUBRA acquisition
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued price relative to intrinsic value
- Strong gross margins and improving cash flow trends
- Strategic positioning in the growing payments‑infrastructure market
Key Metrics & Analysis
Financial Health
Revenue Growth4.50%
Profit Margin-82.73%
P/E Ratio3.2
ROE-43.94%
ROA-0.39%
Debt/Equity84.22
P/B Ratio0.6
Op. Cash Flow$105.4M
Free Cash Flow$45.7M
Industry P/E33.3
Technical Analysis
TrendNeutral
RSI45.6
Support$3.17
Resistance$4.22
MA 20$3.57
MA 50$3.45
MA 200$3.87
MACDBearish
VolumeIncreasing
Fear & Greed Index87.64
Valuation
Fair Value$4.16
Target Price$5.93
Upside/Downside71.84%
GradeUndervalued
TypeValue
Risk Assessment
Beta1.61
Volatility71.06%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.